Nwf Advisory Services Inc. Cytosorbents Corp Call Options Transaction History
Nwf Advisory Services Inc.
- $911 Billion
- Q3 2025
Call Options
3 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.8MCall Options Held
0Put Options Held
0-
Avenir Corp Washington, DC5.08MShares$3.56 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.2MShares$1.54 Million0.0% of portfolio
-
Skylands Capital, LLC2.13MShares$1.49 Million0.31% of portfolio
-
Neuberger Berman Group LLC New York, NY1.6MShares$1.12 Million0.0% of portfolio
-
Cm Management, LLC1.29MShares$901,6891.12% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $30.5M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...